3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
7
Myelodysplastic Syndromes
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Hematologic Neoplasms
5
Lymphoma, Non-Hodgkin
4
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
beta-Thalassemia
2
Lymphoma
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Vasculitis, Central Nervous System
1
Thalassemia
1
Stiff-Person Syndrome
1
Shwachman-Diamond Syndrome
1
Sarcoma, Myeloid
1
Rhabdomyosarcoma
1
Rasmussen subacute encephalitis
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
Opsoclonus-Myoclonus Syndrome
1
Non-Malignant Neoplasm
1
Neuromyelitis Optica
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Interventions
X-Rays
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Vincristine
5
Nuclear Medicine Department, Hospital
5
Biopsy
5
Doxorubicin
4
Etoposide
3
Dactinomycin
3
Cyclophosphamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Temozolomide
2
Radiotherapy, Conformal
2
Radiotherapy
2
Radiation
2
LY3023414
2
Irinotecan
2
talazoparib
1
selinexor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
thymoglobulin
×
1 year
×
Clear all
No trials found.